Related Experiment Video
Updated: May 30, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
The wrong tool for the job: diabetes public health programs and practice guidelines
Urmimala Sarkar1, Andrea López, Karen Black
1Division of General Internal Medicine and Center for Vulnerable Populations, San Francisco General Hospital, University of California, San Francisco, CA 94143-1364, USA. usarkar@medsfgh.ucsf.edu
American Journal of Public Health
|August 20, 2011
Summary
State diabetes programs primarily share existing clinical guidelines but don't prioritize recommendations or adapt them for population health. There's a clear need to align these guidelines with broader public health objectives.
Area of Science:
- Public Health
- Health Policy
- Diabetes Management
Background:
- Diabetes remains a significant public health concern.
- Effective guidelines are crucial for managing diabetes at both individual and population levels.
- The role of state programs in guideline development and dissemination is not fully understood.
Purpose of the Study:
- To assess whether state diabetes programs develop and disseminate diabetes guidelines.
- To understand the characteristics of guidelines disseminated by state programs.
- To identify opportunities for improving guideline alignment with public health goals.
Main Methods:
- A survey was conducted among state diabetes programs.
- The survey focused on guideline development, dissemination practices, and adaptation strategies.
- Data analysis examined current approaches and potential areas for enhancement.
Main Results:
- State programs predominantly disseminate clinical practice guidelines created by subspecialty organizations.
- These programs do not prioritize the numerous recommendations within existing diabetes guidelines.
- Guidelines have not been adapted to emphasize population health over individual patient care.
Conclusions:
- State diabetes programs largely rely on externally developed guidelines.
- A significant opportunity exists for state programs to tailor guidelines for population health.
- Aligning guidelines with public health goals can enhance diabetes control efforts.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:26Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...